
|Articles|February 25, 2021
Calyx Offers Scientific Consulting
Advertisement
Calyx has announced a scientific consulting program aimed at optimizing imaging processes and outcomes to accelerate the clinical development of new medical treatments.
Calyx Scientific Consulting delivers a range of services to meet the needs of new product development, including:
- Evaluating whether imaging is required based on specific endpoints
- Selecting imaging biomarkers to best demonstrate safety and efficacy at each trial phase
- Choosing the ideal image acquisition strategy to best support biomarker requirements
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV
2
Proactive Planning is Key to Mitigating Study Rescue
3
ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results
4
FDA Approves Komzifti for NPM1-Mutated AML Based on Positive Phase I/II KOMET-001 Trial Data
5






.png)



.png)



.png)
.png)
